Our founder, Dr. Nikola Cihoric, with an interdisciplinary team from Insel Gruppe, Kantonsspital St.Gallen, and international collaborators, published a new paper: A CDE-based data structure for radiotherapeutic decision-making in breast cancer.
It covers 46 data points across 31 criteria, capturing 70% of ASTRO guidelines.
To support interoperability, the data model was designed to be both machine-readable and easy to implement across systems, ensuring that critical clinical information can be shared and applied consistently in real-world settings.
This research marks a key step toward clinical decision support that’s usable: practical, AI-ready, and grounded in how care happens in real life.
Proud to see Wemedoo at the heart of it.
Read the full publication: https://link.springer.com/article/10.1186/s12911-025-03036-1
February 27, 2025
Across Global Alliance Selects Wemedoo’s oomnia® as Central Clinical Trial Infrastructure
Company News
October 2, 2024
Interview with Dr. Nikola Čihorić: The Role of Common Data Elements in Breast Cancer Care
Company News
May 7, 2025
New Era of Clinical Trials with oomnia®: Built for Complexity, Designed for Simplicity
Company News